What Human Bio-Organics does

Human Bio-Organics is an Indian pharmaceutical manufacturer founded in 2010 and headquartered in the Mumbai metropolitan area (Mira Road, Thane). The company produces both bulk actives (active pharmaceutical ingredients) and finished pharmaceutical formulations, with stated expertise in organic synthesis, process development, and a controlled supply chain. Its finished-dose portfolio spans multiple therapeutic categories with a heavy emphasis on sterile injectable antibiotics — carbapenems, cephalosporins, penicillins, glycopeptides, glycylcyclines, lincosamides, oxazolidinones, polymyxins, quinolones, and tetracyclines — alongside anticoagulants, analgesics, antiemetics, antifungals, proton pump inhibitors, corticosteroids, blood plasma products, and parenteral nutrition.

The company operates GMP-compliant manufacturing with state-of-the-art analytical facilities meeting USP and other national/international quality standards. Its go-to-market is a subsidiary-driven enterprise field sales model with active operations in over 100 countries, including China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, and Russia. A US subsidiary (Human Bio-Organics LLC in Little Rock, Arkansas) supports North American market access and regulatory filings.

HBO holds over 100 product registrations worldwide with Marketing Authorization Applications in regulated markets including the USA, EU, Australia, and New Zealand. The company supports filings with in-house clinical trial capabilities covering ICH-aligned protocol preparation, study center management, regulatory approvals, monitoring, and bioequivalence studies. The company is supported by a 300-strong workforce of scientists, engineers, and business managers, and the Code of Conduct references listing agreements with BSE and NSE, indicating public listing status. Customer segments are vertical — healthcare providers, hospitals, and pharmacies — with B2B bulk actives supplied to other pharmaceutical manufacturers.

Name

Human Bio-Organics

Legal name

Human Bio Organics Pvt. Ltd.

Website

https://humanbioorganics.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Human Bio-Organics is an Indian pharmaceutical manufacturer producing bulk actives and finished sterile injectable generic drugs across antibiotics, anticoagulants, and other therapeutic categories, selling to healthcare providers and pharmaceutical manufacturers in over 100 countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceutical manufacturing
• Active pharmaceutical ingredients
• Injectable antibiotic formulations
• Bulk drug substances
• Finished dosage formulations

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Bulk Actives (Active Pharmaceutical Ingredients): Manufacturing and sale of high-quality bulk actives at competitive prices, enabled by expertise in organic synthesis and process development with controlled supply chain
2. Finished Pharmaceutical Products: Sale of finished pharmaceutical products across multiple therapeutic categories including antibiotics, anticoagulants, analgesics, antifungals, and other injectable/infusion medications

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Human Bio-Organics manufactures and sells generic pharmaceutical products, including Bulk Actives (Active Pharmaceutical Ingredients) and finished dosage formulations spanning multiple therapeutic categories such as antibiotics (carbapenem, cephalosporin, penicillin, glycopeptide, glycylcycline, lincosamide, oxazolidinones, quinolone, tetracycline, polymyxin, aminoglycoside), anticoagulants, analgesics, antiemetics, antifungals, blood plasma products, parenteral nutrition, proton pump inhibitors, steroids, and iron supplements. The company leverages expertise in organic synthesis and process development combined with a controlled supply chain to deliver high-quality products at competitive prices to healthcare providers and pharmaceutical industry buyers globally.

Product overview

Human Bio-Organics is a pharmaceutical company manufacturing a broad portfolio of generic drug formulations spanning multiple therapeutic categories. Its product portfolio is organized around branded generic drug products, including Bulk Actives and finished dosage forms. Key product lines include carbapenem antibiotics (MYMERO, MYMERO T, MYMERO PLUS, MYMERO XP, MYMERO TZ, HBNEM, REONEM, MYTREAT, XPECTRA, IC2), cephalosporin antibiotics (BIORAZON, T ZONE, T ZONE T, CEFTRICA PLUS EDT, SEE ROXIE, EFSUL, SAFESUL, SAFTREAT, CT, HBTAX, SAFTREAT AV), penicillin antibiotic combinations (HBTAZ, INHIBIT, MOXITUM, XICLAV, UNOTAZ, ERACIL), anticoagulants (HBHEP, HBPARIN), glycopeptide antibiotics (CONFLICT, VANWONDER), blood products (HBO MIN, HBOGLOB), analgesics (DFINICAQUA, HBMOL), proton pump inhibitors (RABIJUST, FROZEN, DLP), and other therapeutic categories. The company operates in both domestic and international markets, with regulatory filings in the USA, EU, Australia, and New Zealand.

Differentiator

Problem solved

Functional benefit

Products and services

• Carbapenem Antibiotics A product line of carbapenem antibiotics including Meropenem-based formulations (MYMERO, HBNEM, REONEM, MYTREAT) in various strengths (500mg, 1gm), Faropenem oral carbapenems (XPECTRA 200mg, XPECTRA 300mg ER), Meropenem+Sulbactam combinations (MYMERO PLUS, MYMERO XP), Meropenem+Tazobactam combinations (MYMERO T, HBNEM T, MYMERO TZ), and Imipenem+Cilastatin (IC2). Used for treating serious bacterial infections in hospital settings.
• Cephalosporin Antibiotics A product line of cephalosporin antibiotics spanning second, third, and fourth generations, including Cefoperazone+Sulbactam (BIORAZON), Ceftriaxone-based products (T ZONE, EFSUL, SAFESUL, CEFTRICA PLUS EDT), Cefepime+Tazobactam (CT 1125), Ceftazidime-based products (SAFETREAT, SAFTREAT AV with Avibactam), Cefotaxime (HBTAX), and Cefuroxime (SEE ROXIE). Used for treating a wide range of bacterial infections.
• Penicillin Antibiotic Combinations A product line of penicillin-class antibiotic combinations including Piperacillin+Tazobactam (HBTAZ, INHIBIT, ERACIL, UNOTAZ), Amoxicillin+Clavulanate (XICLAV), and Amoxicillin+Sulbactam (MOXITUM). Used as broad-spectrum antibiotics for various bacterial infections.
• Glycopeptide Antibiotics A product line of glycopeptide antibiotics including Vancomycin (VANWONDER 500mg) and Teicoplanin (CONFLICT 400mg, CONFLICT 600mg). Used for treating serious Gram-positive bacterial infections including MRSA.
• Aminoglycoside Antibiotics Aminoglycoside antibiotic products including Amikacin Sulphate (HBMYCIN 500mg) used for treating serious infections.
• Glycylcycline Antibiotics Tigecycline-based products (TIGIFAST 50mg, TIGIFAST 100mg) for treating complicated skin and intra-abdominal infections.
• Lincosamide Antibiotics Lincosamide antibiotic products including Clindamycin tablets and injections (HBCLIN 300mg, HBCLIN 300mg 2ML, MYCLIN 600gm) for anaerobic and Gram-positive bacterial infections.
• Oxazolidinone Antibiotics Linezolid tablets (LIZOTREAT 600mg) used for treating Gram-positive infections.
• Quinolone Antibiotics Fluoroquinolone antibiotic products including Levofloxacin (HBLIVO 500mg).
• Tetracycline Antibiotics Doxycycline-based products (DOXUMAN 100mg, DOXUMAN LB with probiotic).
• Polymyxin Antibiotics Polymyxin B injection (POLYME 5LIU) for multidrug-resistant Gram-negative bacterial infections.
• Anticoagulants Anticoagulant products including Heparin (HBHEP 25000, HBHEP 5000) and Enoxaparin Sodium (HBPARIN 40, HBPARIN 60) low molecular weight heparin injections.
• Blood Plasma Products Blood plasma-derived products including Human Albumin (HBO MIN) for plasma volume expansion and hypoalbuminemia treatment, and Human Normal Immunoglobulin (HBOGLOB 5gm, HBOGLOB 10gm) for passive immunization.
• Analgesics and Antipyretics Analgesic and anti-inflammatory products including Diclofenac Sodium IV injection (DFINICAQUA 75mg) and Paracetamol infusion (HBMOL IV 10mg, HBMOL 1gm).
• Antiemetics Ondansetron injections (HBSET 2ML, HBSET 4ML) used to prevent nausea and vomiting.
• Antifungals Amphotericin B IV injection (AMPHOMAN 50mg) used for treating serious systemic fungal infections.
• Proton Pump Inhibitors Proton pump inhibitor products including Rabeprazole (RABIJUST 20mg, RABIJUST L), Pantoprazole (FROZEN 40mg), and Dexlansoprazole MR capsules (DLP 30mg) used to reduce stomach acid.
• Corticosteroids / Steroids Methylprednisolone Sodium Succinate injections (HBMETH 40mg, 125mg, 500mg, 1gm) used as anti-inflammatory and immunosuppressant corticosteroids.
• Iron Supplements Ferric Carboxymaltose injection (HB Built FCM 500mg) used for treatment of iron deficiency anemia.
• Vitamin B12 / Cobalamin Methylcobalamin 1500mcg pre-filled syringe (ECOBAL PFS) used for vitamin B12 deficiency treatment.
• Parenteral Nutrition Amino acid infusions (NEUTRIVEN 200ml, NEUTRATAKE 250ml) for parenteral nutrition support.
• Vasoconstrictors Terlipressin injection (TERLISYNC 1mg/10ml) used to treat low blood pressure.
• Bulk Actives (Active Pharmaceutical Ingredients) High-quality Bulk Actives (APIs) manufactured through expertise in organic synthesis and process development, supported by a controlled supply chain, sold at competitive prices to pharmaceutical industry buyers.

Quantifiable outcome

• Over 100 product registrations worldwide
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Emcure Pharmaceuticals: Indian private/listed generic manufacturer with a strong injectable anti-infective franchise and presence in regulated markets — comparable in product mix, manufacturing base, and international distribution model.
• Aurobindo Pharma: Indian-listed generic pharmaceutical manufacturer with a large sterile injectable portfolio (carbapenems, cephalosporins) and significant US ANDA business — the closest direct comparable to HBO's anti-infective injectable franchise.
• Alkem Laboratories: Indian-listed generic pharma with a meaningful anti-infective and injectable portfolio and US ANDA pipeline — a closely comparable mid-large peer in the same anti-infective space.
• Strides Pharma: Indian-listed generic manufacturer with a focused sterile injectables business and regulated-market emphasis — comparable in scale and therapeutic focus to HBO.
• Lupin Pharmaceuticals: Indian-listed generic manufacturer with strong anti-infective franchises, sterile injectable capabilities, and a US-focused commercial footprint — directly overlapping with HBO's hospital injectable antibiotic business.

Broad incumbents

• Glenmark Pharmaceuticals: Indian-listed pharmaceutical company with generic injectables and a global emerging-markets distribution network — overlapping geographic strategy and product category presence.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company by revenue, with a diversified generics portfolio across injectables, orals, and specialty — directly comparable in product breadth and regulated-market presence.
• Cipla: Large Indian generic pharmaceutical company with a multi-therapeutic portfolio, strong global distribution, and significant presence in antibiotics and respiratory segments — broadly comparable in category reach and international footprint.
• Dr. Reddy's Laboratories: Indian-listed generic manufacturer with strong sterile injectables, biosimilars, and global regulatory filings in US/EU — overlapping injectable antibiotics portfolio and comparable international registration footprint.
• Cadila Healthcare (Zydus): Indian-listed diversified pharmaceutical company with generic injectables, biosimilars, and global filings — broader portfolio but overlapping in sterile anti-infective injectables.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/humanbioorganics-pvt-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Human Bio-Organics